# DOJOLVI
> **NDA213687** · New Drug Application · Sponsor: ULTRAGENYX PHARM INC · Approved 2020-06-30
## Drug
- **FDA Application Number:** NDA213687
- **Application type:** New Drug Application
- **Brand name:** DOJOLVI
- **Generic name:** TRIHEPTANOIN
- **Active ingredients:** TRIHEPTANOIN
- **Dosage form:** LIQUID
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ULTRAGENYX PHARM INC
- **Manufacturer:** Ultragenyx Pharmaceutical Inc.
- **First approval:** 2020-06-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213687)
---
*MORVS · CC0 1.0*